Michael Lee Blum

Insider Reports History

Location
Bedford, MA
Signature
/s/ Paul Alloway, Attorney-in-Fact for Michael L. Blum
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Lee Blum:

Company Role Class Num Shares Value Price $ Report Date Ownership
Homology Medicines, Inc. Chief Commercial Officer Employee Stock Option (Right to Buy) 104,000 $1,395,680 $13.42 23 Feb 2023 Direct
Homology Medicines, Inc. Chief Commercial Officer Restricted Stock Units 17,000 $19,553 $1.15 23 Feb 2023 Direct
Homology Medicines, Inc. Chief Commercial Officer Common Stock 9,408 $5,325 $0.5660 09 Jan 2023 Direct

Insider Reports Filed by Michael Lee Blum

Symbol Company Period Transactions Value $ Form Type Role Filing Time
QTTB Homology Medicines, Inc. 23 Feb 2023 2 $0 4 Chief Commercial Officer 27 Feb 2023, 15:05
QTTB Homology Medicines, Inc. 09 Jan 2023 0 $0 4/A Chief Commercial Officer 20 Jan 2023, 15:05
QTTB Homology Medicines, Inc. 01 Jan 2023 4 $0 4 Chief Commercial Officer 04 Jan 2023, 15:37
QTTB Homology Medicines, Inc. 02 Mar 2022 0 $0 3/A Chief Commercial Officer 20 Jan 2023, 15:05